Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH)

MLA

Fernando Warley, et al. “Results with Allo-SCT in Patients with Relapsed/Refractory HL Treated with Anti-PD-1, a Multicenter Retrospective Cohort Study: Subcommittee of Transplantation and Cellular Therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).” Leukemialymphoma, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c9fdbb996ddee4515f16aa478fc5fb38&authtype=sso&custid=ns315887.

APA

Fernando Warley, Mariano Berro, Silvina Palmer, Martin Castro, Gonzalo Ferini, Milagros Lopez Orozco, Victoria Otero, Jorge Arbelbide, Cecilia Foncuberta, Sebastián Yantorno, & Ana Basquiera. (2022). Results with allo-SCT in patients with relapsed/refractory HL treated with anti-PD-1, a multicenter retrospective cohort study: subcommittee of transplantation and cellular therapy (GATMO-TC) of the Argentinian Hematology Society (SAH). Leukemialymphoma.

Chicago

Fernando Warley, Mariano Berro, Silvina Palmer, Martin Castro, Gonzalo Ferini, Milagros Lopez Orozco, Victoria Otero, et al. 2022. “Results with Allo-SCT in Patients with Relapsed/Refractory HL Treated with Anti-PD-1, a Multicenter Retrospective Cohort Study: Subcommittee of Transplantation and Cellular Therapy (GATMO-TC) of the Argentinian Hematology Society (SAH).” Leukemialymphoma, September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c9fdbb996ddee4515f16aa478fc5fb38&authtype=sso&custid=ns315887.